Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03547518 · ClinicalTrials.gov registry record · NA
Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve Stimulation
A NA study, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03547518 is a NA study that has completed, run by Corewell Health East. The registered enrollment target is 25 participants.
The verdict
NCT03547518, a NA study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The aim of this study is to determine the efficacy of an accelerated course for percutaneous tibial nerve stimulation (PTNS) induction to treat overactive bladder symptoms. The standard 12 weekly induction treatments may be a patient burden and a more rapid induction may speed up symptomatic improvement.
Interventions
- DEVICE Sham treatment
- DEVICE PTNS treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-03-13 |
| Est. Completion | 2022-11-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03547518
The ClinicalTrials.gov registry entry for NCT03547518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham treatment is the first listed.
NCT03547518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03547518 about?
NCT03547518 is a clinical study titled "Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve Stimulation". The aim of this study is to determine the efficacy of an accelerated course for percutaneous tibial nerve stimulation (PTNS) induction to treat overactive bladder symptoms. The standard 12 weekly induction treatments may be a patient burden and a more rapid induction may speed up symptomatic improve...
What is the current status of trial NCT03547518?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-03-13. Estimated completion is 2022-11-17.
What interventions are being tested in trial NCT03547518?
The interventions under investigation include: Sham treatment (DEVICE), PTNS treatment (DEVICE).
Who is sponsoring clinical trial NCT03547518?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.